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Summary statement  
 
The Ca2+-dependent formation of intramitochondrial cAMP by the matrix soluble adenylyl 
cyclase intensifies further Ca2+ uptake into the organelle and this convergence of signalling 
pathways supports steroidogenesis. 
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 Abbreviations 
2-OHE, 2-hydroxy-estradiol; 8CPT-Me-cAMP, 8-pCPT-2’-O-Me-cAMP; AII, angiotensin II;  
[Ca2+]c, cytosolic [Ca
2+]; [Ca2+]m, mitochondrial [Ca
2+]; EHNA, erythro-9-(2-hydroxy-3-
nonyl)adenine; FCCP, Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; H89, N-[2-
[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide; IBMX, 3-
isobutyl-1-methylxanthine; IMM, inner mitochondrial membrane; IMS: intermembrane 
space; MCU, mitochondrial Ca2+ uniporter; mRFP, monomeric Red Fluorescent Protein; mt-
cAMP, mitochondrial cAMP; mt-sAC, mitochondrial soluble adenylyl cyclase; NCLX, 
mitochondrial Na+/Ca2+ exchanger; PDE2, phosphodiesterase 2; PKA, protein kinase A; sAC, 
soluble adenylyl cyclase; t-sAC, truncated (48 kDa), active form of sAC; TMRM, tetramethyl 
rhodamin methylester; WT, wild type; ΔΨm, mitochondrial membrane potential 
  
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
 Abstract 
We have previously demonstrated in H295R adrenocortical cells that the Ca2+-dependent 
production of intramitochondrial cAMP (mt-cAMP) by the matrix soluble adenylyl cyclase 
(sAC) is associated with enhanced aldosterone production. Now we examined whether 
mitochondrial sAC and mt-cAMP fine-tune mitochondrial Ca2+ metabolism to support 
steroidogenesis. Reduction of mt-cAMP formation resulted in decelerated mitochondrial Ca2+ 
accumulation in intact cells during K+-induced Ca2+ signalling and also in permeabilised cells 
exposed to elevated perimitochondrial [Ca2+]. Conversely, the membrane-permeable 8-Br-
cAMP, inhibition of phosphodiesterase 2 and overexpression of sAC in the mitochondrial 
matrix all intensified Ca2+ uptake into the organelle. Identical mt-cAMP dependence of 
mitochondrial Ca2+ uptake was observed in HeLa cells as well. Importantly, the enhancing 
effect of mt-cAMP on Ca2+ uptake was independent from both the mitochondrial membrane 
potential and Ca2+ efflux but was reduced by Epac1 blockade both in intact and in 
permeabilised cells. Finally, overexpression of sAC in the mitochondrial matrix potentiated 
aldosterone production implying that the observed positive feedback mechanism of mt-cAMP 
on mitochondrial Ca2+ accumulation may have a role in the rapid initiation of steroidogenesis. 
 
 
Keywords: mitochondria, cAMP, Ca2+ signal, soluble adenylyl cyclase, Epac, aldosterone  
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 INTRODUCTION 
Aldosterone, secreted by adrenal glomerulosa cells, is the principal regulator of salt-water 
balance. As such it plays a significant role in the control of blood pressure and participates in 
the pathogenesis of cardiovascular, inflammatory and renal diseases (Briet and Schiffrin, 
2010; De Mello, 2017; Prabhu and Frangogiannis, 2016; Rossier et al., 2017; Zhang and 
Lerman, 2017). The most important physiological stimuli of aldosterone secretion are 
angiotensin II (AII) and extracellular K+, their actions are mediated chiefly by cytosolic Ca2+ 
signal (Hattangady et al., 2012; Spät and Hunyady, 2004). Cytosolic Ca2+, beside inducing 
and activating StAR, the steroidogenic acute regulatory protein that transports cholesterol to 
the inner mitochondrial membrane (IMM) (Cherradi et al., 1997), evokes mitochondrial Ca2+ 
signalling (Pitter et al., 2002; Spät and Pitter, 2004) resulting in enhanced reduction of 
pyridine nucleotides (Pralong et al., 1992; Rohács et al., 1997) and production of ATP 
(Tarasov et al., 2012). Moreover, the mitochondrial Ca2+ signal and NAD(P)H formation 
within mitochondria are essential for the hypersecretion of aldosterone (Spät et al., 2012; 
Wiederkehr et al., 2011). 
The soluble adenylyl cyclase (sAC, encoded by ADCY10), a cAMP generating enzyme 
activated by HCO3
- (Chen et al., 2000; Lefkimmiatis et al., 2013; Steegborn et al., 2005b) and 
Ca2+ (Jaiswal and Conti, 2003), is present in the mitochondrial matrix (Acin-Perez et al., 
2009b). Mitochondrial Ca2+ signals result in the enhanced formation of cAMP by sAC within 
the mitochondrial matrix of HeLa cells, rat cardiomyocytes (Di Benedetto et al., 2014; Di 
Benedetto et al., 2013) as well as of human adrenocortical H295R cells (Katona et al., 2015). 
In addition to the increased formation of ATP (Acin-Perez et al., 2009b; Di Benedetto et al., 
2013; Wang et al., 2016), mitochondrial cAMP (mt-cAMP) may have cell type specific roles 
as exemplified by the reduced aldosterone production in adrenocortical cells after the knock-
down of sAC (Katona et al., 2015). Mitochondrial Ca2+ is one of the key regulators of 
aldosterone synthesis (Wiederkehr et al., 2011) and it also boosts pyridine nucleotide 
reduction which may also favour steroid production (Pralong et al., 1992; Spät et al., 2012). 
Therefore in the present study we examined whether the hormone secretion promoting action 
of mt-cAMP reflects an effect on mitochondrial Ca2+ handling itself. We show that mt-cAMP 
enhances mitochondrial Ca2+ uptake and boosts subsequent hormonal response in H295R 
human adrenocortical cells. The effect of mt-cAMP on mitochondrial Ca2+ handling is not 
mediated by changes of the mitochondrial membrane potential (ΔΨm) or Ca2+ efflux but 
requires the cAMP-regulated guanine nucleotide exchange factor Epac1. Importantly, this 
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 feedback mechanism was detected also in HeLa cells, showing that it is not confined to 
steroid producing cells. 
 
RESULTS 
 
Inhibition of mt-cAMP formation attenuates mitochondrial Ca2+ accumulation during 
Ca2+ signalling in intact H295R cells 
First we examined the effects of 2-OHE, a membrane permeable sAC inhibitor (Steegborn et 
al., 2005a), on Ca2+ signalling in AII-stimulated H295R cells. The drug significantly reduced 
mitochondrial Ca2+ uptake rate without a similar effect on the cytosolic response (Fig. S1A). 
Further experiments, however, revealed that 2-OHE reduces the fluorescence of the 
membrane potential sensitive dye TMRM both in the mitochondria and the nuclei (Fig. S1B). 
2-OHE failed to influence m in permeabilised cells (Fig. S1C,D) suggesting that the 
reduction of TMRM fluorescence in intact cells was due to plasma membrane depolarisation. 
Nevertheless, we regarded the results obtained with 2-OHE in AII-stimulated intact cells 
inconclusive. 
H295R cells produce voltage-dependent Ca2+ influx with ensuing mitochondrial Ca2+ 
signal when stimulated with K+ (Szanda et al., 2006). Knocking down sAC with a verified 
siRNA sequence (MR2 (Di Benedetto et al., 2013; Katona et al., 2015) and Fig. S2D) 
significantly reduced net mitochondrial Ca2+ uptake rate without any effect on cytosolic Ca2+ 
response in K+-stimulated cells (Fig. 1A,B). Importantly, knock-down of sAC slightly 
hyperpolarised mitochondria both under resting conditions and during Ca2+ signalling as 
compared to control cells (Fig. 1C). Since hyperpolarisation of the mitochondria would 
increase rather than decrease mitochondrial Ca2+ uptake rate, these findings strongly suggest 
that attenuating mt-cAMP formation impedes mitochondrial Ca2+ uptake in a ΔΨm 
independent manner. 
 
Manipulation of the mt-cAMP system in permeabilised cells influences mitochondrial 
Ca2+ accumulation independently of ΔΨm 
With the aim of minimizing the effect of extramitochondrial factors, next we analysed the mt-
cAMP dependence of mitochondrial Ca2+ uptake in permeabilised cells in which 
perimitochondrial [Ca2+] can be adjusted. 2-OHE was used to inhibit sAC and erythro-9-(2-
hydoxy-3-nonyl)adenine (EHNA), a selective inhibitor of PDE2A (Acin-Perez et al., 2011) 
and as such an enhancer of mt-cAMP formation in H295R (Katona et al., 2015) and HeLa 
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 cells (Di Benedetto et al., 2013), was applied to increase [mt-cAMP]. Ca2+ accumulation was 
significantly dampened by 2-OHE (Fig. 2A) and EHNA markedly accelerated the uptake 
(Fig. 2B). These observations were corroborated by the finding that the knock-down of sAC 
reduced mitochondrial Ca2+ uptake into the mitochondria of permeabilised H295R cells (Fig. 
2C) and we observed a similar reduction of Ca2+ uptake in permeabilised sAC-silenced HeLa 
cells (Fig. 2D). 
The sAC – Ca2+ interplay was further investigated by combining a cAMP analogue and 
sAC silencing. The membrane permeable cAMP analogue 8-Br-cAMP strongly intensified 
mitochondrial Ca2+ accumulation (Fig. 3A) without any measurable effect on ΔΨm (Fig. 3B) 
supporting the notion that mt-cAMP enhances mitochondrial Ca2+ accumulation 
independently of ΔΨm. Moreover, 8-Br-cAMP increased mitochondrial Ca2+ uptake to 
comparable levels in both the control and sAC silenced permeabilised H295R cells (Fig. 3C) 
implying that cAMP is the downstream effector of sAC. 
 
Overexpression of sAC in the mitochondrial matrix accelerates mitochondrial Ca2+ 
uptake and intensifies aldosterone secretion 
In order to study the effect of increased intramitochondrial cAMP formation on Ca2+ 
handling, we generated wild-type (WT) and enzymatically inactive, mitochondrially targeted 
versions of the sAC. H295R cells express the truncated (~48 kDa) form of sAC which 
localizes predominantly to the particulate fraction (Katona et al., 2015). Although the full-
length sAC mRNA (NM_018417.5; 4832 bp CDS) could be found in these cells (Fig. S2A), 
for our mitochondria-targeted constructs we used the sequence of the physiologically 
occurring, enzymatically enhanced truncated version of sAC (Buck et al. 1999; Steegborn, 
2014) (Figs. S2B, S3 and S4). Interestingly, two sAC isoforms were consistently amplified 
from H29R cells; one corresponding to the canonical sequence and the other lacking a short 
section (Δ215-276; Fig. S5A) from the C1-C2 region which links the two catalytic domains 
(Steegborn, 2014). 
In order to obtain functionally compromised mutants, two amino acid changes were 
introduced (Fig. S2B). In the double mutant sAC the D99A mutation aims to eliminate Mg2+ 
binding and the N412A to abolish ribose binding (Steegborn, 2014). As expected, HeLa cells 
expressing double mutant mt-sAC exhibited significantly reduced mt-cAMP production 
during Ca2+ signalling or when stimulated with HCO3
‒, the direct activator of sAC (Chen et 
al.; Steegborn, 2014) (Fig. S2C). 
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 If mt-cAMP intensifies mitochondrial Ca2+ uptake then one could expect a reduced Ca2+ 
accumulation when an enzymatically inactive sAC is overexpressed in mitochondria. This 
was indeed the case as the overexpression of the double mutant mt-sAC markedly reduced 
the rate of mitochondrial Ca2+ accumulation in both permeabilised H295R and HeLa cells as 
compared to the overexpression of the wild-type cyclase (Figs 4A,B). (We obtained identical 
results with the adrenocortical isoforms of sAC (Fig. S5B) strongly suggesting that the linker 
region is indeed dispensable for the enzymatic activity.) Moreover, the difference in Ca2+ 
uptake rate between WT and mutant sAC was preserved also in the presence of the NCLX 
blocker CGP-37157 (Fig. S6). In order to test the effect of mt-cAMP-dependent enhancement 
of Ca2+ uptake on the biological response of adrenocortical cells, that is steroid synthesis, we 
measured 2 h basal and AII-stimulated aldosterone production in cells transfected with WT or 
mutant mt-sAC (Fig. 4C). Cells expressing mutant mt-sAC exhibited blunted steroidogenesis 
(as compared to WT mt-sAC expressing counterparts) highlighting the contribution of mt-
cAMP to the hormonal response. 
 
The role of Epac-1 and protein kinase A in mediating mt-cAMP effect on Ca2+ uptake 
Next we studied the involvement of recognized cAMP effectors, protein kinase A (PKA) and 
the guanine nucleotide exchange factor Epac, in conveying the enhancing effect of mt-cAMP 
on Ca2+ uptake. ESI-09, a pan-Epac inhibitor (Almahariq et al., 2013) reduced mitochondrial 
Ca2+ uptake rate in permeabilised H295R cells (Fig. 5A). In view of data confirming (Zhu et 
al., 2015) or challenging the specificity of ESI-09 (Rehmann, 2013), we also examined the 
effect of the structurally unrelated Epac-1 inhibitor CE3F4 (Courilleau et al., 2012). This 
drug also decelerated mitochondrial Ca2+ uptake in permeabilised as well as in AII-stimulated 
intact H295R cells without affecting the cytosolic Ca2+ signal (Fig. 5B,C). Importantly, the 
conventional PKA inhibitor H-89 failed to affect Ca2+ uptake rate but decreased steady-state 
[Ca2+]m in permeabilised cells (Fig. 5B). And finally, the enhancing effect of mt-sAC 
overexpression on Ca2+ uptake was lost if Epac-1 was inhibited with CE3F4 (Fig. 5D) 
strongly suggesting that Epac is downstream of mt-sAC and mt-cAMP. Altogether, these data 
strongly suggest that Epac has an essential role in the control of initial Ca2+ uptake whereas 
PKA, acting with a longer lag-time, may contribute to maintaining elevated [Ca2+]m. 
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DISCUSSION 
Calcium uptake into mitochondria occurs by diffusion through the voltage dependent anion 
channels (VDACs) in the outer mitochondrial membrane followed by the transport through 
the IMM by the Mitochondrial Ca2+ Uniporter (MCU) multiprotein complex, the structure of 
which has been recently elucidated (MCU: (Baughman et al., 2011; De Stefani et al., 2011), 
MCUb: (Raffaello et al., 2013), MICU1: (Perocchi et al., 2010), MICU2: (Plovanich et al., 
2013), EMRE: (Sancak et al., 2013), for reviews see e.g. (De Stefani et al., 2016; Mammucari 
et al., 2016)). The transport is driven by the 150-180 mV (inside negative) mitochondrial 
membrane potential. The ensuing mitochondrial Ca2+ signal modulates such substantial 
mitochondrial processes as pyridine nucleotide reduction (McCormack et al., 1990), ATP 
synthesis (Jouaville et al., 1999), apoptosis (Hajnóczky et al., 2000) and even cell type 
specific functions including insulin and aldosterone production (Wiederkehr et al.). However, 
the short-term control of Ca2+ uptake under physiologically relevant conditions has remained 
elusive (De Stefani et al., 2016). In the present study we reveal a hitherto unrecognized 
mechanism of this control, specifically that mt-cAMP enhances mitochondrial Ca2+ uptake. 
Ca2+ influx into the mitochondrial matrix activates mt-sAC which, in turn, produces mt-
cAMP, a process first described in HeLa cells and cultured cardiac myocytes (Di Benedetto 
et al., 2013). In our previous study on H295R adrenocortical cells (Katona et al., 2015), we 
observed that the inhibition or the knockdown of sAC as well as the buffering of 
mitochondrial Ca2+ by the targeted expression of a Ca2+ binding protein (S100G) significantly 
reduced AII-elicited mt-cAMP signalling whereas the inhibition of mitochondrial PDE2A 
with EHNA (Acin-Perez et al., 2011) enhanced cAMP production within the organelle. The 
biological significance of mt-cAMP signalling was demonstrated by the reduced aldosterone 
production after the inhibition or knockdown of sAC. Since [Ca2+]m is one of the key factors 
regulating aldosterone secretion (Spät et al., 2012), in the present study we examined whether 
the secretagogue effect of mt-cAMP could be mediated by an action of this messenger on 
mitochondrial Ca2+ uptake itself. Moreover, we extended our study of mitochondrial Ca2+ 
handling to HeLa cells so as to assess whether the mt-cAMP – Ca2+ interplay is unique to 
endocrine cells or is a more general phenomenon. 
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 Applying experimental approaches that manipulate mt-cAMP signalling we found that 1) 
knock-down of sAC resulted in decelerated mitochondrial Ca2+ uptake in intact H295R cells; 
2) increasing the intramitochondrial cAMP activity by the inhibition of PDE2A, with the 
cAMP analogue 8-Br-cAMP or with the overexpression of mitochondrial sAC all accelerated 
Ca2+ uptake in permeabilised H295R and HeLa cells; 3) mt-cAMP dependent changes in 
mitochondrial Ca2+ uptake were not dependent on changes in ΔΨm or Ca2+ efflux; 4) the 
augmenting effect of mt-cAMP on mitochondrial Ca2+ accumulation was sensitive to the 
inhibition of the Rap-GEF Epac-1; 5) overexpressing WT sAC within mitochondria 
intensified aldosterone production as compared to the enzymatically compromised sAC 
mutant. 
Knock-down of sAC decelerated mitochondrial Ca2+ accumulation during Ca2+ signalling 
in K+-stimulated intact H295R cells. Although sAC in H295R cells locates predominantly to 
the particulate fraction (Katona et al., 2015), by studying mitochondrial Ca2+ uptake in 
permeabilised cells one may minimize the influence of extramitochondrial factors (Bernardi 
et al., 1999) and cytosolic cAMP (and quite possibly cytosolic sAC) are also lost under such 
conditions. Importantly, data obtained in permeabilised cells confirmed the findings in intact 
cells as both inhibition and knock-down of sAC impeded Ca2+ uptake in H295R and HeLa 
cells. Moreover, overexpression of WT sAC in the mitochondrial matrix accelerated Ca2+ 
accumulation into the organelle in both cell types. 
We found that H295R cells, besides the canonical sAC variant, also express an isoform 
lacking amino acids 215-276 within the linker region of the enzyme. This adrenocortical 
isoform had identical effects on mitochondrial Ca2+ uptake as the canonical 48-kD version, 
confirming the notion that the linker region is dispensable for enzymatic activity (Steegborn, 
2014). (The deletion in this delta mutant respects exon-intron boundaries and thus the Δ215-
276 sAC isoform may probably be regarded as a naturally occurring variant.) 
Theoretically, accelerated mitochondrial Ca2+ accumulation may reflect increased Ca2+ 
conductance via the MCU, inhibited Ca2+ efflux through NCLX, larger driving force and, 
naturally, the combination thereof. The maximal rate of mitochondrial Ca2+ uptake far 
exceeds that of Ca2+ efflux in H295R cells (A.S. and G.S., unpublished observation) 
rendering the Na+/Ca2+ exchanger (NCLX) an unlikely target of mt-cAMP. Nevertheless, the 
possibility that mt-cAMP inhibits NCLX, and thereby accelerates Ca2+ accumulation, had to 
be considered. The enhanced Ca2+ uptake in sAC-overexpressing cells was preserved in the 
presence of CGP-37157, a conventional inhibitor of NCLX. As to the driving force, the 
membrane-permeable cAMP analogue 8-Br-cAMP increased mitochondrial Ca2+ uptake rate 
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 but failed to influence ΔΨm. Moreover, knock-down of sAC slightly hyperpolarized 
mitochondria yet it reduced the rate of Ca2+ accumulation. Altogether, changes in ΔΨm or 
Ca2+ efflux are not required for the mt-cAMP dependent modulation of mitochondrial Ca2+ 
handling. 
Apart from cyclic nucleotide-activated cation channels of the plasma membrane two 
downstream signalling pathways of cyclic AMP are generally accepted: activation of protein 
kinase A and of the Rap1 exchange factor Epac (Seino and Shibasaki, 2005). The location of 
PKA within the mitochondrial matrix is not sufficiently elucidated. Due to binding of PKA to 
several anchoring proteins in the OMM and possibly also to the outer surface of the IMM 
(see (Di Benedetto et al., 2013; Lefkimmiatis et al., 2013)), data on the exact location of PKA 
in the „inner” mitochondria (Sardanelli et al., 2006; Schwoch et al., 1990) are not conclusive 
and reports on the location of PKA within the matrix are also conflicting (Acin-Perez et al., 
2011; Monterisi et al., 2017). There is also no agreement whether PKA activates the electron 
transport chain and ATP production (Acin-Perez et al., 2009a; Di Benedetto et al., 2013; 
Lefkimmiatis et al., 2013). In our present study, the conventional PKA inhibitor H89 failed to 
exert a significant effect on initial mitochondrial Ca2+ uptake. Nevertheless, with some delay 
H89 decreased steady-state [Ca2+]m. The real biological significance of this latter effect 
warrants further studies but the reported side-effects of H89 should also be kept in mind 
(Lochner and Moolman, 2006). 
Besides PKA, the cAMP-activated guanylyl nucleotide exchange factors Epac1 and 2 are 
possible mediators of the mt-cAMP effect on mitochondrial Ca2+ uptake. The presence of 
Epac1 in mitochondria (Qiao et al., 2002), in mitoplasts (Wang et al., 2016), in the IMM and 
also in the matrix (Fazal et al., 2017) has already been documented and an N-terminal 
mitochondrial target sequence on Epac1 has been identified (Fazal et al., 2017). As to the role 
of Epac on mitochondrial Ca2+ metabolism, we are aware of two reports on myocardial cells. 
However, the data are conflicting inasmuch as those of Wang and co-workers (Wang et al., 
2016) indicate an inhibitory whereas those of Fazal et al. (Fazal et al., 2017) show a 
stimulatory effect for Epac. It should be emphasized that non-physiological conditions were 
applied in these experiments: mitochondria were isolated from hypertrophic rat hearts (Wang 
et al., 2016) and mitochondrial Ca2+ accumulation in murine cardiac cells was observed in the 
presence of supraphysiological (50 M) extramitochondrial Ca2+ (without data on uptake 
rate) (Fazal et al., 2017). In our experiments a pan-Epac inhibitor or a specific Epac1 
inhibitor reduced mitochondrial Ca2+ accumulation in intact H295R and also in permeabilised 
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 H295R and HeLa cells. Moreover, the overexpression of mt-sAC failed to accelerate the 
mitochondrial Ca2+ response in the presence of Epac inhibitors indicating that this Rap-GEF 
is the downstream effector of mt-cAMP in this respect. Taken together, whereas the data on 
cardiac cells (Fazal et al., 2017; Wang et al., 2016) contribute to our knowledge on Epac-
dependent cell death, our experiments show that intramitochondrial cAMP and Epac 
signalling support mitochondrial Ca2+ accumulation also at physiological Ca2+ 
concentrations. 
Only few data are available about the role of Epac in the adrenal cortex. The report that 
only about 60 % of the cAMP-mediated effects of ACTH on transcription were dependent on 
PKA in Y1 mouse adrenal cells (Schimmer et al., 2006) gave rise to the idea that the PKA-
independent actions were mediated by Epac (Lewis et al., 2016). In murine Y1 cells the 
expression of Epac2 could be detected with immunocytochemistry, yet the cell-permeable 
Epac activator 8-pCPT-2’-O-Me-cAMP failed to simulate the effect of cAMP either on the 
expression of steroidogenic factors or on 24-hr steroid secretion (Aumo et al., 2010). In 
bovine glomerulosa cells both 8-pCPT-2’-O-Me-cAMP and AII activated the Epac substrate 
Rap1 but neither of them stimulated 1-hour aldosterone production (Gambaryan et al., 2006). 
Considering that 8-pCPT-2’-O-Me-cAMP is not PDE-resistant (Laxman et al., 2006), its 
breakdown during cell incubation cannot be ruled out. Due to well-known species differences 
in the control of aldosterone secretion (Spät and Hunyady, 2004; Spät et al., 2016) these data 
should not be extrapolated to human cells. Indeed, our findings that knock-down of sAC 
inhibits (Katona et al., 2015) whereas overexpression of mt-sAC augments aldosterone 
production, together with the observation that mt-sAC fails to affect mitochondrial Ca2+ 
uptake in the presence of Epac inhibitors, strongly suggest that intramitochondrial Epac is 
involved in the regulation of the steroidogenic response in the human adrenal cortex. 
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CONCLUSION 
The combination of work described here and in past studies (Katona et al., 2015) reveals a 
positive feedback loop controlling mitochondrial Ca2+ handling: Ca2+ triggers the formation 
of mt-cAMP which, in turn, recruits Epac and enhances Ca2+ uptake (Fig. 6). This positive 
feedback is a new example for the convergence of Ca2+ and cAMP signalling (Spät et al., 
2016). Although excessive function of this system may lead to cell death, it may also have 
great significance in situations of emergency, especially when rapid cellular response is 
required. Changes in basal mt-cAMP metabolism modified mitochondrial Ca2+ uptake rate 
without detectable delay suggesting that even basal mt-sAC activity has a role in triggering 
the biological response. In case of glomerulosa cells it may be assumed that during severe 
salt-water loss (e.g. haemorrhage, diarrhoea, strenuous physical exercise in hot environment) 
aldosterone secretion is triggered by the simultaneous actions of AII and corticotrophin (Spät 
and Hunyady, 2004) and is enhanced by the here described Ca2+ ‒ mt-cAMP ‒ Ca2+ positive 
feedback system. In addition, given that mt-cAMP enhances mitochondrial Ca2+ uptake in 
HeLa cells as well, the present observations may be of broader cell physiological 
significance. 
 
MATERIALS AND METHODS 
Materials 
OPTI-MEM, Lipofectamine LTX, RNAiMax, Fluo-4 AM, Rhod-2 AM, tetramethyl 
rhodamine methylester (TMRM) and Mitotracker Deep Red as well as the BCA assay kit 
were purchased from Invitrogen (Thermo Fisher Scientific, Waltham, MA), Fura-2 AM from 
Tocris (Elliswille, MO), Ultra-MEM from Lonza (Basle, Switzerland). UltroSer G was from 
Bio-Sepra (Cergy-Saint-Christophe, France). siRNA for silencing sAC (MR2, (Di Benedetto 
et al., 2013)) and Control siRNA (Universal Negative Control, SIC001) were obtained from 
Sigma-Aldrich (St. Louis, MO, USA). 4mt-H30 was constructed by G. Di Benedetto and T. 
Pozzan, as described (Cano Abad et al., 2013). Mt-inverse Pericam was gifted by Prof. A. 
Miyawaki (Saitama, Japan). 4mt-D2 was prepared as described (Fülöp et al., 2011). CE3F4 
and 8-Br-cAMP was obtained from Cayman (Ann Arobor, MI), other chemicals were 
obtained from Sigma-Aldrich. 
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Cell culture and transfection 
H295R and HeLa cells were cultured as previously described (Fülöp et al., 2011). Briefly, 
H295R cells (CRL-2128, ATCC, Manassas, VA) were cultured in DMEM/Ham’s F12 (1:1 
v/v) completed with 1% ITS+, 2% UltroSer G, 100 U ml-1 penicillin and 100 µg ml-1 
streptomycin. HeLa cells (CLL-2, ATCC) were grown in DMEM containing 10% heat-
inactivated FBS, 100 U ml-1 penicillin and 100 µg ml-1 streptomycin. Passages numbered 3-
20 were used. Before experiments, H295R cells were serum-starved overnight (14-16 h) and 
HeLa cells for 3-5 h. Incubation conditions for aldosterone experiments are described below. 
Cells (2.5-5x104 H295R or 2-5x104 HeLa cells) were plated onto 25-mm diameter circular 
glass coverslips on day 1 and transfected on day 2 with plasmid DNA (0.5 μg/coverslip but 
HeLa cells were transfected with 1 μg/coverslip 4-mt-H30 DNA) using Lipofectamine LTX 
(H295R) or Fugene HD (HeLa) according to the manufacturer’s protocol. For silencing sAC, 
on day 2, cells were transfected with 50 pmol MR2 siRNA or control RNA in Ultra-MEM 
using lipofectamine RNAiMax. If H295R cells were co-transfected with plasmid DNA and 
siRNA, RNAiMax was used as reagent. Experiments were conducted on day 4 or, in case of 
mt-cAMP measurements, on day 5. 
 
RNA isolation, cDNA preparation and qPCR 
RNA isolation and cDNA synthesis were performed as described (Ella et al., 2016). For the 
determination of GAPDH expression by quantitative real-time PCR (qPCR) the LightCycler 
480 system (Roche) with the FastStart DNA Master SYBR Green (Roche) was used. Primers: 
forward: 5’– AAGGTGAAGGTCGGAGTCAACG –3’; reverse: 5’– 
GACGGTGCCATGGAATTTGC –3’. 
 
Confocal microscopy 
A Zeiss LSM710 confocal laser scanning microscope (operated with ZEN 11.0 software) and 
a 40*/1.3 water immersion objective (Plan-Apochromat, Zeiss) were used. For monitoring 
cytosolic and mitochondrial Ca2+ signals, the cells were preloaded with Fluo-4 and Rhod-2 or 
transfected with mitochondria targeted inverse Pericam (mt-i-Pericam), as specified in the 
figure legends. Fluorescence was monitored in multitrack mode while excitation and 
emission detection wavelengths were set as described previously (Fülöp et al., 2011; Katona 
et al., 2015). The optical slice was 5 m in the cytosolic and 3 m in the mitochondrial 
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 channels but the latter was 1.5 m in the colocalisation studies (Fig. S2 and S3). In kinetic 
studies fluorescence intensity was normalized to the average 20-60-s intensity measured 
before stimulation (FO). The linear section of the normalized Ca
2+ curves was regarded as rate 
of Ca2+ uptake. Uptake rate was expressed as (F/F0)/t for Rhod-2 or (F0/ F)/t in case of 
mt-i-Pericam. 
For the measurement of mitochondrial membrane potential (ΔΨm), TMRM was used. 
TMRM (15-25 nM) was present throughout the entire experiment including drug pre-
incubation periods. At the end of each run, ΔΨm was dissipated with 10 μM FCCP + 8 μg ml-
1 oligomycin and TMRM fluorescence was normalized to that measured after FCCP + 
oligomycin addition (FFCCP). Excitation and emission were achieved as described previously 
(Fülöp et al., 2011). 
 
Measurements with fluorescent wide-field microscopy 
An inverted microscope (Axio Observer D1, Zeiss) equipped with a 40x1.4 Plan-Apochromat 
oil immersion objective (Zeiss) and a Cascade II camera (Photometrics) were used for 
epifluorescence measurements. Mitochondrial [Ca2+] ([Ca2+]m) and cytosolic [Ca
2+] ([Ca2+]c) 
in intact cells were monitored using 4mt-D2-cpV (4mt-D2) and Fura-2, resp., and [Ca
2+]m in 
permeabilised cells with mt-i-Pericam. Mitochondrial Ca2+ uptake rate was calculated as 
described previously (Fülöp et al., 2011). cAMP level in the mitochondrial matrix was 
monitored by means of fluorescence resonance energy transfer (FRET), using 4mt-H30 as 
described earlier (Katona et al., 2015). 
 
Superfusion 
Microscopic experiments were carried out at room temperature. For kinetic studies in intact 
cells the coverslips were superfused with a modified Krebs-Ringer solution containing 140 
mM Na+, 4.5 mM K+, 1.2 mM Ca2+, 0.5 mM Mg2+, 5 mM Hepes and 2 mM HCO3 (pH 7.4). 
Cells were permeabilised with 25 μg ml-1 digitonin in Ca2+-free cytosol-like medium (see 
below) for 6 minutes. For superfusion of permeabilised cells a pH 7.1 cytosol-like solution 
was used containing 129 mM K+, 10 mM Na+, 1.13 mM Mg2+, 120 mM HEPES, 2 mM 
EGTA, 2 mM ADP, 2 mM pyruvate and 2 mM malate (for H295R) or succinate (for HeLa). 
To adjust the [Ca2+] and [Mg2+] of the cytosol-like media, EGTA, HEDTA, Ca2+ and Mg2+ 
were added as calculated by the chelator software (Fabiato, 1988). The flow rate of 
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 superfusions was ~ 1 ml·min-1. The solutions were applied with a solenoid valve-equipped, 
gravity-driven superfusion system, terminating at ~2 mm from the selected cells! 
 
Aldosterone measurements 
Cells were transfected with the appropriate sAC constructs by means of electroporation 
(2x106 cells in 100 μl resuspension buffer, 1600 V 20 ms; Neon Transfection System, 
Thermo Fisher Scientific) and plated onto 24-well plates (5x105 cells/well) on day one. 
Following incubation in the complete medium (Section Cell culture and transfection), on day 
3 the medium was changed to one with 0.1% UltroSer G content for overnight incubation. On 
day 4, after a 30-min preincubation in serum-free medium (supplemented with 0.01% BSA) 
the cells were incubated at 37oC for 2 hours in a similar medium, with or without angiotensin 
II. Aldosterone content of the supernatant and cellular protein amount were determined with 
DERCW100 RIA kit (Demeditec (Kiel, Germany)) and BCA assay (Thermo Fisher 
Scientific, Waltham, MA), respectively. 
 
DNA constructs 
To create the 5mt-sAC-mRFP constructs, the truncated version of soluble adenylate cyclase 
(t-sAC, 1-469 amino acids) was amplified from serum deprived human adrenocortical H295R 
cell cDNA. The following primers were used: forward, 5’ – 
ATATGTCGACGATGAACACTCCAAAAGAAGAATTCC – 3’; reverse, 5’– 
ATATACCGGTCCTGCTCCGACTTTCTCAGTACGGCCC – 3’. PCR products were 
digested and cloned into the pmRFP-N1 vector at SalI and AgeI sites. Five consecutive 
mitochondrial target signals of the human cytochrome c oxidase VIII (5mt) were subcloned at 
the N-terminal end of sAC. V5- and His-tagged constructs were generated by amplifying the 
5mt-sAC section from the above plasmid and cloning into the pcDNA3.1/V5-His TOPO 
vector (Thermo Fisher Scientific, Waltham, MA USA). Amino acid changes (D99A, N412A) 
were introduced by site-directed mutagenesis using the following primers: sAC_D99A 
forward: 5’ – GCAGGTGCTGCACTGCTAGCC – 3’; sAC_D99A reverse 5’ – 
GCAGTGCAGCACCTGCAAATTTCAGG – 3’; sAC_N412A forward 5’ – 
GTCGCCTTAGCTGCCAGGATGATGATGTACTACC -3’; sAC_N412A reverse 5’ – 
GGCAGCTAAGGCGACTTTTTGACCAATGACTG – 3’. Every construct was verified by 
sequencing (Microsynth, Balgach, Switzerland). 
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 STATISTICS 
Means + s.e.m. are shown unless otherwise specified. In some experiments, in cases of high 
impact outliers, minimal and maximal values have been uniformly excluded in all groups 
(trimmed mean). In some cases, for better visibility, mean + or ‒ s.e.m. are shown and in 
microscopic experiments with 1Hz < acquisition frequency, only every 2nd or 3rd data points 
are marked by actual symbols. For estimating significance of differences, Student’s unpaired 
t-test, Mann-Whitney and Kolmogorov-Smirnov test, one and two-way ANOVA and post-
hoc tests were used, as appropriate. Data were analysed with Statistica 13, Microsoft Excel 
2016 and with GraphPad Prism 5 software. 
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Figures 
 
 
 
 
 
Figure 1. K+-evoked cytosolic and mitochondrial Ca2+ signals in sAC silenced H295R 
cells 
(A) [Ca2+]c and [Ca
2+]m in K
+-stimulated control (blue circles) and sAC siRNA transfected 
cells (red triangles). Cells were transfected with the mitochondria-targeted ratiometric probe 
4mt-D2-cpV (mt-D2) and with siRNA against sAC or control RNA (non-silencing dsRNA) 
and loaded with Fura-2 AM (100 or 500 nM) for 30 min. Fura-2 ([Ca2+]c) and mt-D2 
([Ca2+]m) ratios (R) were normalized to baseline values (RO). Following a control superfusion 
period, the cells were stimulated with 25 mM K+. Mitochondrial Ca2+ uptake rate displayed 
non-Gaussian distribution and, accordingly, the mean and median of [Ca2+]m considerably 
deviated from one another (not shown). Therefore, right panel shows median values with 
interquartile range. For statistics see Panel B. (B) Statistical analysis of K+-evoked peak 
cytosolic Ca2+ signals (left) and mitochondrial Ca2+ uptake rates (right). Right graph shows 
individual data points and median value (horizontal lines); n = 24 and 20 for control and sAC 
siRNA treated cells, resp. *p = 0.028 (Kolmogorov-Smirnov test). (C) Mitochondrial 
membrane potential (ΔΨm) under resting conditions or Ca2+ signalling in cells with different 
mt-cAMP status. Control cells (elevated [mt-cAMP]) were transfected with non-silencing 
dsRNA and were exposed to the PDE inhibitor IBMX (100 μM, 30 min) whereas cells 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
 transfected with sAC siRNA (reduced [mt-cAMP]) were exposed to solvent (0.1% DMSO, 
30 min). Following a 2 min control period, cells were exposed to AII (10 nM) for an 
additional 2 min before ΔΨm was dissipated with FCCP + oligomycin. TMRM, IBMX or 
vehicle were present throughout the entire experiment. n = 37 control RNA and 39 sAC 
siRNA treated cells; *p = 0.0248 and #p = 0.0221 (two-way ANOVA and Sidak’s multiple 
comparison test). 
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Figure 2. Effect of mt-cAMP on mitochondrial Ca2+ uptake in permeabilised cells 
Ca2+ accumulation into mitochondria of permeabilised H295R cells in the presence of 2-OHE 
(A) or EHNA (B). Cells were loaded with 2 μM Rhod-2 AM for 30 min at 37 °C and then 
kept at room temperature for 15 min. Following permeabilisation, the cells were superfused 
with Ca2+-free cytosol-like medium and [Ca2+] was subsequently raised to 2 or 5 μM Ca2+ as 
indicated. Rhod-2 fluorescence data were measured by confocal microscopy and were 
normalized to control period (FO). Drugs were present throughout the entire experiment. 
Column bar graphs show mean mitochondrial Ca2+ uptake rates. Panel A: n = 51 vehicle and 
60 2-OHE (20 μM) treated cells; ****p < 0.0001, Mann-Whitney test. Panel B: n = 39 
vehicle and 32 EHNA (10 µM) treated cells; ***p = 0.0002, Mann-Whitney test. (C) 
Mitochondrial Ca2+ uptake in sAC-silenced permeabilised H295R cells. Two days after co-
transfection with sAC siRNA or control RNA and mitochondrially targeted GFP, dye 
loading, permeabilisation and confocal microscopy were carried out as described for Panel A. 
After the control period [Ca2+] of the cytosol like medium was raised from 0 nM to 2 μM as 
indicated. Only GFP+ cells were regarded as RNA-transfected and used for statistics. Column 
bar graphs show mean mitochondrial Ca2+ uptake rate. n = 19 control and 18 sAC silenced 
cells; *p = 0.0279 (t-test with Welch’s correction). Inset magnifies the section indicated by 
the box (dashed lines). (D) Mitochondrial Ca2+ uptake in sAC-silenced permeabilised HeLa 
cells. Two days after transfection with control or sAC siRNA dye loading, permeabilisation 
and confocal microscopy were carried out as described for Panel C. [Ca2+] of the cytosol like 
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 medium was raised from 100 nM to 2 or 5 μM as indicated. Column bar graphs show mean 
mitochondrial Ca2+ uptake rate. n = 40 control and 23 sAC-silenced cells at 2 μM [Ca2+] and 
26 control and 40 sAC-silenced cells at 5 μM [Ca2+]; *p = 0.0067 and **p < 0.0001 (2-way 
ANOVA and Sidak’s post-hoc test). 
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Figure 3. Mitochondrial Ca2+ uptake and ΔΨm in the presence of 8-Br-cAMP in H295R 
cells 
(A) Effect of 8-Br-cAMP on mitochondrial Ca2+ uptake in permeabilised H295R cells. Cells 
expressing mt-i-Pericam were pre-incubated (37 °C) in the presence or absence of 1 mM 8-
Br-cAMP for 60 min. Following permeabilisation, the cells were incubated with or without 1 
mM 8-Br-cAMP for additional 15 min in a Ca2+-free cytosol like medium. After the control 
superfusion period, [Ca2+] was raised in the medium from 0 to 2 µM. Confocal and wide-field 
fluorescent microscopic measurements of i-Pericam (expressed as FO/F) gave identical results 
and therefore data were pooled. n = 36 control and 56 8-Br-cAMP treated cells; **p < 0.0001 
(Mann-Whitney test). (B) The effect of 8-Br-cAMP on ΔΨm. Cells were incubated with 8-Br-
cAMP, permeabilised and pre-incubated with 8-Br-cAMP again as described for Panel A. n = 
123 control and 85 8-Br-cAMP treated. (p = 0.319, t-test.) (C) Effect of 8-Br-cAMP 
(triangles) on mitochondrial Ca2+ uptake in cells transfected with control RNA (full blue 
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 symbols) or sAC siRNA (empty red symbols). Cells were co-transfected with sAC siRNA or 
control RNA and with mitochondrially targeted GFP. Rhod-2 loading, permeabilisation and 
microscopy were performed as described for Fig.2 A and, again, only GFP+ cells were 
regarded as RNA-transfected and used for statistics. After permeabilisation cells were 
incubated with 1 mM 8-Br-cAMP in Ca2+-free cytosol like medium for 15 min. Then, cells 
were superfused with Ca2+-free cytosol-like medium and perimitochondrial [Ca2+] was raised 
to 2 μM Ca2+. Upper panel shows mean curves (+ s.e.m.); lower panel shows mean 
mitochondrial Ca2+ uptake rate (+ s.e.m.). Number of observations: control RNA 28, control 
RNA + 8-Br-cAMP 30, sAC siRNA 18, sAC siRNA + 8-Br-cAMP 20. *p = 0.0487, #p = 
0.0143 and ***p = 0.0001 (ANOVA followed by Dunn’s post-hoc test). 
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Figure 4. Effect of mt-sAC overexpression on mitochondrial Ca2+ accumulation and 
aldosterone production 
(A) Mitochondrial Ca2+ uptake in permeabilised H295R cells expressing wild-type or mutant 
mitochondrially targeted sAC. Cells were co-transfected with a plasmid coding the 
mitochondria-targeted Ca2+ sensitive fluorescent protein inverse-Pericam (i-Pericam) together 
with mitochondrially targeted sAC (mt-sAC-mRFP) or the double mutant version (D99A 
N412A) thereof. Two days after transfection, the cells were permeabilised and superfused 
with a Ca2+ free cytosol-like medium before raising [Ca2+] to 2 μM Ca2+. Pericam 
fluorescence was measured by confocal microscopy and was normalized to the control period 
and expressed as FO/F; only mRFP positive cells were analysed. Column bar graphs show 
mean mitochondrial Ca2+ uptake rate. n = 23 mt-sAC and 19 D99A N412A expressing cells; 
**p < 0.0001, Mann-Whitney test. (B) Mitochondrial Ca2+ uptake in permeabilised HeLa 
cells WT or mutant mt-sAC variants. Cells were co-transfected with mt-i-Pericam and WT or 
the double mutant (D99A N412A) mt-sAC-mRFP. For further details see Panel A. Right 
panel shows average mitochondrial Ca2+ uptake rate. n = 76 WT mt-sAC and 57 double 
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 mutant sAC expressing cells; **p < 0.0001 (Mann-Whitney test). (C) Aldosterone production 
in H295R cells expressing wild-type or mutant mt-sAC. Cells were transfected with plasmids 
coding for WT or double mutant mt-sAC-V5 and basal and AII-stimulated 2h aldosterone 
production was measured as described in Methods. Horizontal lines show mean. p = 0.0045 
for WT vs. double mutant, p < 0.0001 for the effect of AII and p = 0.35 for interaction; two-
way ANOVA. 
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Figure 5. Role of Epac and PKA in the control of mitochondrial Ca2+ uptake 
(A) Mitochondrial Ca2+ accumulation in permeabilised H295R cells exposed to the pan-Epac 
inhibitor ESI-09. Cells were pre-incubated with 20 μM ESI-09 or DMSO for 20 min in 
DMEM/F12 at 37 C°. After permeabilisation cells were incubated with 20 μM ESI-09 for 
further 10 min in a Ca2+ free cytosol like medium. Following a 30 s Ca2+-free control 
superfusion [Ca2+] was raised to 2 μM. Pericam fluorescence was measured with confocal 
microscope and expressed as FO/F. Column bar graphs display mean mitochondrial Ca
2+ 
uptake rate. n = 35 vehicle and 28 ESI-09 treated cells; **p < 0.0001 (t-test). (B) 
Mitochondrial Ca2+ uptake in permeabilised H295R cells in the presence of PKA (H-89) or 
Epac-1 (CE3F4) inhibitors. Cells expressing mt-i-Pericam were pre-incubated with 20 μM 
CE3F4 or 20 μM H-89 or 0.04% DMSO for 1 h in DMEM/F12 at 37 C°. After 
permeabilisation cells were incubated with the appropriate drug for further 10 min in a Ca2+-
free cytosol like medium. Following a 30 s Ca2+-free control superfusion [Ca2+] was raised to 
2 μM. Pericam fluorescence was measured with confocal microscope and expressed as FO/F. 
Inset magnifies the section indicated by the box (dashed lines). Lower left graph displays 
mean mitochondrial Ca2+ uptake rate whereas lower right graph shows mitochondrial Ca2+ 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
 peak. n = 25, 22 and 23 for vehicle, CE3F4 and H-89 treated cells, respectively. **p < 
0.0001, *p = 0.0439; #p = 0.0228 for vehicle vs. H89 and ##p = 0.0045 for vehicle vs. CE3F4 
(two separate ANOVA analysis both followed by Sidak’s post-hoc test). (C) Effect of Epac-1 
inhibition on mitochondrial Ca2+ handling during AII-induced Ca2+ signalling in H295R cells. 
For the simultaneous measurement of [Ca2+]m and [Ca
2+]c cells were co-loaded with 2 μM 
Rhod-2 AM and 2 μM Fluo-4 AM. Then, cells were pre-incubated with 20 μM CE3F4 or 
vehicle (0.04% DMSO) for 10 min. After 30 s control superfusion, the cells were exposed to 
1 nM AII. Fluorescence data were monitored by confocal microscopy and normalized to the 
60 s control period. Lower left graph: maximal F/FO Fluo-4 value in the first 60 s of 
stimulation ([Ca2+]c peak); lower middle graph: the slope of the linear section of the [Ca
2+]m 
curves; lower right graph: area under the curve (a.u.c.) of the [Ca2+]m data integrated for the 
first 60 s of stimulation. n = 19 vehicle and 32 CE3F4 treated cells; ***p = 0.0046 (unpaired 
t-test), *p = 0.026 (Mann-Whitney test). (D) Effect of the Epac-1 inhibitor CE3F4 on Ca2+ 
uptake in permeabilised HeLa cells. The cells were treated as described for Panel B with the 
exception that following [Ca2+] was raised from 100 nM (rather than from 0 nM) to 5 μM. n = 
19, 16 and 27, 11 for solvent or CE3F4 treated wild-type sAC transfected cells and solvent or 
CE3F4 treated double mutant (D99A N412A) mt-sAC transfected cells, respectively. **p = 
0.0037, *p = 0.0215, (two-way ANOVA followed by Tukey’s post-hoc test). 
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Figure 6. Schematic illustration of the proposed mt-cAMP-dependent positive feedback 
control of mitochondrial Ca2+ uptake Red arrows represent activation. (Templates from the 
Servier medical art website (http://www.servier.com/Powerpoint-image-bank) were used for 
this figure.) 
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Figure S1. Effect of the sAC inhibitor 2-OHE on mitochondrial Ca
2+
 signalling and ΔΨm in H295R cells 
(A) Simultaneous measurement of [Ca
2+
]c and [Ca
2+
]m in intact AII-stimulated H295R cells in the presence or absence of the 
sAC inhibitor 2-OHE (20 μM). Cells were transfected with the mitochondria-targeted ratio-metric probe 4mt-D2-cpV (mt-D2) 
and loaded with Fura-2 AM (0.1 or 0.5 μM) for 30 min. Fura-2 ([Ca2+]c) and mt-D2 ([Ca
2+
]m) ratios (R) were normalized to 
baseline values (RO). Following a control superfusion period, the cells were stimulated with 1 nM AII. Vehicle or 2-OHE was 
present throughout the entire experiment including dye loading. n = 9 and 10 for vehicle and 2-OHE, resp.; ***p < 0.0001 for 
the effect of 2-OHE, 2-way ANOVA. The column bar graph shows peak cytosolic Ca
2+
 signal and the dot graph displays initial 
mitochondrial Ca
2+
 uptake rate. Ca
2+
 uptake rate was determined as the slope of the [Ca
2+
]m curve on its linear section. n = 9 and 
10 for vehicle and 2-OHE, resp.; *p = 0.012 (Mann-Whitney test). (2-OHE slightly reduced the AII-evoked cytosolic Ca
2+
 
response as compared to the vehicle treated group (data not shown). So as to analyse mitochondrial Ca
2+
 signals in the two 
groups within a comparable range of [Ca
2+
]c, we excluded control cells (2 out of 11) displaying larger cytosolic Ca
2+
 signals than 
the maximum seen in the 2-OHE-treated group.) (B) Effect of 2-OHE on mitochondrial (upper graph) and nuclear (lower graph) 
TMRM fluorescence in intact H295R cells. Cells were loaded with 15 nM TMRM in a modified Krebs-Ringer solution (see 
Methods) at room temperature for 30 min. After loading the cells were exposed to 20 μM 2-OHE or 0.2% ethanol (vehicle) for 5 
min and then to 5 μM FCCP as indicated. TMRM fluorescence was monitored with confocal microscopy and intensities of 
mitochondrial regions of interest (ROIs) were normalised to that measured after FCCP addition (F/FFCCP) whereas the nuclear 
TMRM signal was normalised to the average fluorescence before drug addition (F/FO). Mean + s.e.m. are shown; n = 21 and 20 
for vehicle and 2-OHE, resp. (C and D) Effect of 2-OHE on ΔΨm in permeabilised H295R cells. Cells were permeabilised and 
then exposed to 2-OHE (20 μM) or vehicle (0.2% ethanol) for 5 min (C) or 30 min (D) before ΔΨm was dissipated with 5 μM 
FCCP as indicated. TMRM (25 μM) was present throughout the entire measurement and fluorescence was normalised to that 
measured after FCCP addition (F/FFCCP). n = 24 2-OHE and 21 vehicle treated cells for Panel C and 25 2-OHE and 30 vehicle 
treated cells for Panel D.  
J. Cell Sci. 131: doi:10.1242/jcs.215178: Supplementary information
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Figure S2. Construction of WT and double mutant sAC isoforms and their effect on mt-cAMP production 
(A) PCR revealing the presence of the endogenous canonical full-length sAC mRNA (NM_018417.5; 4832 bp CDS) 
in H295R cells. Serum starved H295R cells and human peripheral blood monocytes were subjected to RNA isolation 
and reverse transcription as described in Methods. Primers used: 
forward 5’ – ATATGTCGACGATGAACACTCCAAAAGAAGAATTCC – 3’; 
reverse 5’ – ATATACCGGTCCTGCTCCGAAATGATTGTCCACGGTATTAGC – 3’. 
(B) Schematic domain structure of the mitochondria-targeted truncated sAC constructs. (C) Effect of double mutation 
on histamine and bicarbonate induced mt-cAMP formation in intact HeLa cells. Cells co-expressing the 
mitochondrially targeted cAMP sensor 4mt-H30 with WT or double mutant mt-sAC-V5 were kept in a modified 
Krebs-Ringer medium (see Subsection 2.6) for 30 min at RT. Following a brief control period, the cell were 
superfused with 5 μM histamine for 3 min and then with 50 mM HCO3‒ for additional 3 min. Fluorescence was 
monitored by wide-field fluorescent microscopy and 4mt-H30 FRET (CFP/YFP) was normalized to the average 
measured during control period (R/RO). Bars show the mean maximal R/RO values (+ s.e.m.) detected during 
histamine and HCO3‒ stimulation. n = 28 WT and 21 mutant sAC expressing cells; **p = 0.0041 for the effect of 
WT vs. double mutant (two-way ANOVA). (D) Knock-down of sAC as verified by PCR. HeLa cells were transfected 
with sAC-directed siRNA or control dsRNA. Total RNA isolation, reverse transcription and PCR were performed as 
described in Methods; primers used for amplifying sAC (48 kDa) were as follows: 
5’ – ATATGTCGACGATGAACACTCCAAAAGAAGAATTCC – 3’; 
reverse 5’– ATATACCGGTCCTGCTCCGACTTTCTCAGTACGGCCC– 3’. 
Expression of sAC was normalized to that of GAPDH. n = 4-4 for both control and siRNA treated; **p = 0.0021, 
unpaired t-test with Welch’s correction.  
J. Cell Sci. 131: doi:10.1242/jcs.215178: Supplementary information
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Figure S3. Co-localization of mt-sAC constructs with the mitochondrial Ca
2+
 sensor mt-i-Pericam in intact 
H295R and HeLa cells 
Cells co-transfected with mt-i-Pericam and different mt-sAC constructs were subjected to confocal microscopy as 
described in Methods (but the optical slice was 1.5 μm). Profiles show fluorescent intensities along a randomly 
chosen section (dashed line) as normalized to the minimum and maximum (0-100%) values in the pertinent channel. 
Images are representative for at least 12 cells per mt-sAC construct from at least 2 independent preparations.  
J. Cell Sci. 131: doi:10.1242/jcs.215178: Supplementary information
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Fig. S4 
 
 
 
Figure S4. Co-localization of mt-sAC constructs with the mitochondrial cAMP sensor 4mt-H30 in intact HeLa 
cells 
Cells co-transfected with 4mt-H30 and different mt-sAC constructs were subjected to confocal microscopy as 
described in Methods (but the optical slice was 1.5 μm). Profiles show fluorescent intensities along a random line 
(dashed line) as normalized to the minimum and maximum (0-100%) values in the pertinent channel. Images are 
representative for at least 9 cells per mt-sAC construct from 2 independent preparations. 
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Figure S5. Mitochondrial Ca
2+
 uptake in permeabilised H295R cells expressing the adrenocortical (Δ215-276) 
versions of mt-sAC 
(A) Schematic domain structure of the mitochondria-targeted adrenocortical-type sAC constructs. (B) Mitochondrial 
Ca
2+
 uptake was measured in cells co-expressing mt-i-Pericam and WT or double mutant Δ215-276 mt-sAC-mRFP 
constructs as described in Fig.4 A. n = 15 WT and 17 mutant expressing cells; **p = 0.0046 (Mann-Whitney test). 
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Figure S6. Mitochondrial Ca
2+
 uptake in the presence of the NCLX inhibitor CGP-37157 in HeLa cells 
Cells co-expressing mt-i-Pericam and WT or double mutant mt-sAC-mRFP were permeabilised and superfused with 
Ca
2+
 free cytosol-like medium supplemented with 25 μM CGP-37157 for 220 s before uptake was initiated with 2 μM 
Ca
2+
. Data collection and analysis was carried out as described in Fig.4 B. n = 49 WT and 48 mutant sAC expressing 
cells; ***p = 0.001 (Mann-Whitney test). 
J. Cell Sci. 131: doi:10.1242/jcs.215178: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
